1. EP-1372 External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC). (April 2019) Authors: Käsmann, L.; Abdo, R.; Eze, C.; Dantes, M.; Taugner, J.; Gennen, K.; Roengvoraphoj, O.; Rades, D.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1374 ECOG-PS and its changes in inoperable stage III NSCLC patients treated with chemoradiotherapy. (April 2019) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1375 Heterogeneity score in inoperable stage III NSCLC patients treated with definitive chemoradiotherapy. (April 2019) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1792: Pre-fraction shift and intra-fraction drift of the prostate due to perineal ultrasound probe pressure. (April 2016) Authors: Ballhausen, H.; Manapov, F.; Kolberg, A.; Thum, P.D.; Ganswindt, U.; Belka, C.; Li, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1804: A comparative analyse of prostate positioning guided by transperineal 3D ultrasound and cone beam CT. (April 2016) Authors: Li, M.; Ballhausen, H.; Hegemann, N.S.; Reiner, M.; Tritschler, S.; Manapov, F.; Ganswindt, U.; Belka, C. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0144: Maximum response and PCI are important prognostic factors in LD SCLC patients staged with cMRI. (April 2016) Authors: Eze, C.; Roengvoraphoj, O.; Niyazi, M.; Gerum, S.; Hildebrandt, G.; Fietkau, R.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-0780 Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy. (April 2019) Authors: Gennen, K.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Taugner, J.; Neumann, J.; Mille, E.; Tufman, A.; Huber, R.M.; Orth, M.; Reu, S.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-0997: Evaluation of outcome and toxicity of Durvalumab treatment after CRT in inoperable stage III NSCLC. (November 2020) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Roengvoraphoj, O.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-0998: Durvalumab treatment after CRT in inoperable stage III NSCLC – a German radiation oncology survey. (November 2020) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Roengvoraphoj, O.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-0999: Deciphering the tumor microenviroment based on PD-L1 expression and CD8 + TILs density in LA-NSCLC. (November 2020) Authors: Käsmann, L.; Gennen, K.; Taugner, J.; Eze, C.; Karin, M.; Roengvoraphoj, O.; Neumann, J.; Tufman, A.; Orth, M.; Reu, S.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗